Cargando…
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus
BACKGROUND: Coronavirus disease 2019 (COVID-19) has been declared a global pandemic. COVID-19 is more severe in people with diabetes. The identification of risk factors for predicting disease severity in COVID-19 patients with type 2 diabetes mellitus (T2DM) is urgently needed. METHODS: Two hundred...
Autores principales: | Cheng, Yangyang, Yue, Ling, Wang, Zhiyang, Zhang, Junxia, Xiang, Guangda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690319/ https://www.ncbi.nlm.nih.gov/pubmed/33288414 http://dx.doi.org/10.1016/j.jdiacomp.2020.107809 |
Ejemplares similares
-
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
por: Peñaloza, Hernán F., et al.
Publicado: (2021) -
Lymphopenia: A useful predictor of COVID-19 disease severity and mortality
por: Toori, Kaleem Ullah, et al.
Publicado: (2021) -
Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
por: Zhang, Yaguang, et al.
Publicado: (2020) -
Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19
por: Shahridan Faiez, Tasnim, et al.
Publicado: (2022)